Stephen W. Webster
|Age||Total Calculated Compensation||This person is connected to 48 board members in 4 different organizations across 8 different industries.|
See Board Relationships
Mr. Stephen W. Webster has been the Chief Financial Officer at Spark Therapeutics Inc. since July 2014. Mr. Webster served as Managing Director of Gleacher & Company Securities, Inc. from January 2007 to June 2008. Mr. Webster served as the Chief Financial Officer and Senior Vice President of Optimer Pharmaceuticals, Inc. since June 5, 2012 until 2013 and served as its Principal Accounting Officer and Senior Vice President of Finance. Mr. Webster served as Managing Director ...
101 Hudson StreetPhone: 201-333-8819
Jersey City, New Jersey 07302
Board Members Memberships*
Director, Chairman of Compensation Committee, Member of Audit Committee & Member of Nominating & Corporate Governance Committee
University of Pennsylvania - The Wharton School
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Alexander Macrae M.B., Ch.B, Ph.D., MRCP||Chief Executive Officer, President and Director|
Sangamo BioSciences, Inc.
|Matthew Kapusta||Chief Executive Officer and Member of Management Board|
|€600.0K||Compensation as of Fiscal Year --.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.